Cargando…

The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene

Detalles Bibliográficos
Autores principales:	Giustetto, Carla, Scrocco, Chiara, Giachino, Daniela, Rapezzi, Claudio, Mognetti, Barbara, Gaita, Fiorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419677/ https://www.ncbi.nlm.nih.gov/pubmed/28491588 http://dx.doi.org/10.1016/j.hrcr.2015.07.001

Ejemplares similares

Computational analysis of arrhythmogenesis in KCNH2 T618I mutation-associated short QT syndrome and the pharmacological effects of quinidine and sotalol
por: Zhang, Shugang, et al.
Publicado: (2022)

Shortening of the Short Refractory Periods in Short QT Syndrome
por: Rollin, Anne, et al.
Publicado: (2017)

Artificial Intelligence ECG Analysis in Patients with Short QT Syndrome to Predict Life-Threatening Arrhythmic Events
por: Pasero, Eros, et al.
Publicado: (2023)

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
por: Lenhoff, Hanna, et al.
Publicado: (2021)

Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome
por: Fujisawa, Taishi, et al.
Publicado: (2020)

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients
por: Ricci, Maria Teresa, et al.
Publicado: (2014)

Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K(+) Channel
por: El Harchi, Aziza, et al.
Publicado: (2012)

Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation
por: Decloedt, Annelies, et al.
Publicado: (2018)

Maternal mosaicism in long QT syndrome due to a pathogenic variant in KCNH2
por: Sawyer, Briana L., et al.
Publicado: (2020)

Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG ‘hotspot’ mutation
por: Du, Chunyun, et al.
Publicado: (2022)

The Brugada syndrome: risk stratification
por: Gaita, Fiorenzo, et al.
Publicado: (2023)

Outpatient intravenous sotalol load to replace 3-day admission oral sotalol load
por: Von Bergen, Nicholas H., et al.
Publicado: (2019)

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

The Brugada syndrome: pharmacological therapy
por: Giustetto, Carla, et al.
Publicado: (2023)

Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome
por: Aizawa, Takanori, et al.
Publicado: (2023)

Long QT syndrome and left ventricular non-compaction in a family with KCNH2 mutation: A case report
por: Caiffa, Thomas, et al.
Publicado: (2022)

Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)

Trafficking Defect and Proteasomal Degradation Contribute to the Phenotype of a Novel KCNH2 Long QT Syndrome Mutation
por: Mihic, Anton, et al.
Publicado: (2011)

Nearly Fatal Torsade de Pointes with Sotalol
por: Strohmer, Bernhard, et al.
Publicado: (2003)

Intravenous sotalol for conversion of atrial flutter in infants
por: Aljohani, Othman A., et al.
Publicado: (2018)

Use of intravenous sotalol in newborns with supraventricular tachycardia
por: Kim, Hannah, et al.
Publicado: (2017)

Sotalol‐induced generalized and ocular myasthenia gravis
por: Sharifkazemi, Mohammadbagher, et al.
Publicado: (2019)

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
por: Bellin, Milena, et al.
Publicado: (2013)

An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort
por: Kerr, Shona M., et al.
Publicado: (2019)

Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole‐exome sequencing
por: Fazelifar, Amir Farjam, et al.
Publicado: (2023)

KCNH2 mutation c.3099_3112del causes congenital long QT syndrome type 2 with gender differences
por: Ke, ZunPing, et al.
Publicado: (2023)

Intravenous sotalol for the management of postoperative junctional ectopic tachycardia
por: Valdés, Santiago O., et al.
Publicado: (2018)

Mortality and ventricular arrhythmias in patients with atrial fibrillation on sotalol
por: Lenhoff, H, et al.
Publicado: (2023)

Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy
por: Chen, Chris, et al.
Publicado: (2023)

Novel KCNH1 Mutations Associated with Epilepsy: Broadening the Phenotypic Spectrum of KCNH1-Associated Diseases
por: von Wrede, Randi, et al.
Publicado: (2021)

Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2
por: Christiansen, Michael, et al.
Publicado: (2014)

A Novel KCNH2 S981fs Mutation Identified by Whole-Exome Sequencing Is Associated with Type 2 Long QT Syndrome
por: Cheng, Yu-Wen, et al.
Publicado: (2023)

Subclinical Left Ventricular Dysfunction in Severe Obesity and Reverse Cardiac Remodeling after Bariatric Surgery
por: Frea, Simone, et al.
Publicado: (2020)

Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death
por: Pappone, Carlo, et al.
Publicado: (2023)

MON-618 National In-Hospital Trends in Acquired Hypothyroidism
por: Kumar, Monisha Priyadarshini, et al.
Publicado: (2019)

Lopinavir/ritonavir/sotalol: Various toxicities: 9 case reports
Publicado: (2021)

Amiodarone/sotalol: Acute lung injury and hypotension: case report
Publicado: (2021)

Severe Hypoglycemia Associated With Oral Sotalol Use in Two Children
por: Miyake, Christina Y., et al.
Publicado: (2021)

Long QT syndrome in chromosome 7q35q36.3 deletion involving KCNH2 gene: Warning for chlorpheniramine prescription
por: Di Stolfo, Giuseppe, et al.
Publicado: (2019)

Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
por: Ono, Makoto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q9u9rb3shgkp0e3pk6hm2erlg4